Comerica Securities’s PRA Health Sciences, Inc. PRAH Stock Holding History

Comerica Securities’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,799	Closed	-$1.29M	–	505
2021 Q2	$1.29M	Buy	7,799 +332	+4%	+$55.4K	0.1%	187
2021 Q1	$1.15M	Buy	7,467 +842	+13%	+$114K	0.09%	199
2020 Q4	$831K	Buy	6,625 +3,844	+138%	+$430K	0.07%	231
2020 Q3	$282K	Sell	2,781 -930	-25%	-$94.8K	0.03%	353
2020 Q2	$361K	Buy	3,711 +1,276	+52%	+$119K	0.03%	319
2020 Q1	$202K	Sell	2,435 -5,051	-67%	-$493K	0.02%	383
2019 Q4	$832K	Sell	7,486 -693	-8%	-$71.3K	0.08%	228
2019 Q3	$812K	Buy	+8,179	New	+$812K	0.08%	219

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Comerica Securities's PRAH Position: Q3 2021 in Review

Comerica Securities sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 7,799 shares — an estimated $1.29M sold.

Comerica Securities first reported a position in PRAH in Q3 2019 and held it in 8 quarters. The position peaked at $1.29M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Comerica Securities reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Comerica Securities sold 7,799 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.29M.
Comerica Securities first reported a position in PRA Health Sciences, Inc. in Q3 2019 and held it in 8 quarters.
Comerica Securities's PRA Health Sciences, Inc. position peaked at $1.29M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Comerica Securities's 13F filing for Q3 2021, filed 10 Nov 2021.